RxDoctor Payments Data

Charla Knapp, NP

Family · Natchez, MSNPI 1083851026

Payments from drug & device makers

$547in general payments, 2019–2025

Across 27 payments — averaging $20.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$118
  • Phathom Pharmaceuticals, Inc.$92
  • AbbVie$78
  • Johnson & Johnson$41
  • Lilly USA, LLC$35
  • Novo Nordisk$34
  • plus $150 from 8 others

What the payments were for

  • Food & beverage$547100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$547 in reported general payments places this provider in the 55th percentile of 3,007 family providers in Mississippi.

See all family providers in Mississippi

Medicare billing

Part B allowed, 2024
$12,098
Medicare patients
93
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide46$59,809
JardianceEmpagliflozin44$44,825
LinzessLinaclotide24$27,354
XareltoRivaroxaban18$19,493
MounjaroTirzepatide12$18,525
EliquisApixaban25$16,640
Trelegy ElliptaFluticasone/Umeclidin/Vilanter20$12,421
TradjentaLinagliptin11$8,592
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl16$2,847
Albuterol Sulfate HfaAlbuterol Sulfate69$2,441
Potassium Chloride97$1,611
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen103$1,351
Lantus SolostarInsulin Glargine,hum.Rec.Anlog17$1,325
Gabapentin87$1,248
Pantoprazole Sodium101$1,105

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$34$59,80946 claims
Boehringer IngelheimJardiance, Tradjenta$17$53,41755 claims
AbbVieLinzess$78$27,35424 claims
Johnson & JohnsonXarelto$41$19,49318 claims
Lilly USA, LLCMounjaro$35$18,52512 claims
GSKTrelegy Ellipta$16$12,42120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,007 family providers in Mississippi.

Other family in Natchez

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →